Holbrook JT, Davis MD, Hubbard LD, Martin BK, Holland GN, Jabs DA, Gilpin AKG, Meinert CL, Reshef DS for the Studies of Ocular Complications of AIDS Research Group. Risk factors for advancement of cytomegalovirus retinitis in patients with AIDS. Arch Ophthalmol 118:1196-1204, 2000.
Martin BK, Gilpin AMK, Jabs DA, Wu AW for the Studies of Ocular Complications of AIDS Research Group. Reliability, validity, and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis. J Clin Epidemiol 54:376-386, 2001.
Jabs DA, Martin BK, Forman MS, Dunn JP, Davis JL, Weinberg DV, Biron KK, Baldanti F, for the Cytomegalovirus Retinitis and Viral Resistance Study Group. Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. J Infect Dis 183:333-337, 2001.
Carlson MC, Tschanz JT, Norton MC, Welsh-Bohmer K, Martin BK, Greene J, Breitner JCS. H2 Histamine Receptor Blockade in the Treatment of Alzheimer’s Disease: A randomized, double-blind, placebo-controlled trial of nizatidine. Alzheimer Dis Assoc Disord 16:24-30, 2002.
Jabs DA, Martin BK, Forman MS, Dunn JP, Davis JL, Weinberg DV, Biron KK, Baldanti F for the Cytomegalovirus Retinitis and Viral Resistance Study Group. Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8. Am J Ophthalmol 132:700-710, 2002.
Martin BK, Meinert CL, Breitner JCS for the ADAPT Research Group. Double placebo design in a prevention trial for Alzheimer’s disease. Controlled Clin Trials 23:93-99, 2002 .
Hu H, Jabs DA, Forman MS, Martin BK, Dunn JP, Weinberg DV, Davis JL for the Cytomegalovirus Retinitis and Viral Resistance Study Group. Comparison of cytomegalovirus UL97 gene sequences in the blood and vitreous of patients with AIDS and cytomegalovirus retinitis. J Infect Dis 185:861-867, 2002.
Jabs DA, Martin BK, Forman MS, Hubbard L, Dunn JP, Kempen JH, Davis JL, Weinberg DV for the Cytomegalovirus Retinitis and Viral Resistance Study Group. Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis. Am J Ophthalmol 135:26-34, 2003.
Kempen JH, Martin BK, Wu AW, Barron B, Thorne JE, Jabs DA for the Studies of Ocular Complications of AIDS Research Group. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active anti-retroviral therapy. Ophthalmology 110:987-995, 2003.
Weinberg A, Jabs DA, Chou S, Martin BK, Lurain NS, Forman, MS, Crumpacker C, for the Cytomegalovirus Retinitis and Viral Resistance Study Group and the Adult AIDS Clinical Trials Group Cytomegalovirus Laboratories. Mutations conferring foscarnet resistance in a cohort of patients with acquired immune deficiency syndrome and cytomegalovirus retinitis. J Infect Dis 187:777-784, 2003.
Hubbard LD, Ricks MO, Martin BK, Bressler, NM, Kempen JH, Dunn JP, Jabs DA, for the Cytomegalovirus Retinitis and Viral Resistance Study Group. Comparability of two fundus photograph reading centers in grading CMV retinitis progression. Am J Ophthalmol 137:426-434, 2004.
Rosenberg PB, Onyike C, Katz I, Weintraub D, Porsteinsson A, Mintzer J, Schneider L, Rabins P, Meinert C, Martin B, Lyketsos C for Depression in Alzheimer’s Disease Study-2. Operationalization of criteria for “Depression of Alzheimer’s Disease”. Int J Geriatric Psychiatry 20:119-127, 2005.
Semba RD, Martin BK, Kempen JH, Thorne JE, MacGregor RR, Wu AW for the SOCA Research Group. The impact of anemia on energy and physical functioning in individuals with acquired immunodeficiency syndrome. Arch Intern Med 165:2229-2236, 2005.
Jabs DA, Martin BK, Forman MA, Ricks MO, for the Cytomegalovirus Retinitis and Viral Resistance Research Group. Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis. J Infect Dis 192:640-649, 2005.
Martin BK, Wu AW, Gelman R, Mitsuyasu RT for the Adult AIDS Clinical Trials Group. Quality of life in a clinical trial of HAART alone or with either intravenous or subcutaneous IL-2 administration. JAIDS 40:428-433, 2005.
Jabs DA, Martin BK, Ricks MO, Forman MS for the Cytomegalovirus Retinitis and Viral Resistance Study Group. Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome. J Infect Dis 193:1728-1737, 2006.
Martin B, Buffington ALH, Welsh-Bohmer KA, Brandt J for the ADAPT Research Group. Time of day affects episodic memory in older adults. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (in press).
Martin BK, Frangakis CE, Rosenberg PB, Mintzer JE, Katz IR, Porsteinnson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Niederehe GL, Lyketsos CG for the DIADS-2 Research Group. Design of the Depression in Alzheimer’s Disease Study-2. Am J Geriatr Psychiatry 14:920-930, 2006.
ADAPT Research Group. Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer’s Disease Anti-inflammatory Prevention Trial (ADAPT). PloS Clinical Trials 1(7):e33, 2006.
ADAPT Research Group. Naproxen or celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology 68:1800-1808, 2007.
Martin BK, Rick MO, Forman MS, Jabs DA for the Cytomegalovirus Retinitis and Viral Resistance Study Group. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis. Clin Infect Dis 44:1001-1008, 2007.
ADAPT Research Group. Cognitive function over time in ADAPT: results of a randomized controlled trial of naproxen sodium and celecoxib. Arch Neurol (in press).
